Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04882319 · ClinicalTrials.gov registry record · Phase 1
Irritation and Sensitization Study of HP-5000 Topical System
A Phase 1 study, sponsored by Noven Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
NCT04882319: Completed Phase 1 study, sponsored by Noven Pharmaceuticals.
NCT04882319 is a Phase 1 study that has completed, run by Noven Pharmaceuticals. The registered enrollment target is 200 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (233% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04882319, a Phase 1 study, has completed, sponsored by Noven Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
Study Summary
This study will assess skin irritation and sensitization for HP-5000 patch in healthy subjects.
Primary Outcome
To evaluate skin irritation after exposure to HP-5000, placebo and saline.
Interventions
- DRUG HP-5000 Topical Patch
- DRUG HP-5000 Placebo Patch
- DRUG Saline Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-06-03 |
| Est. Completion | 2022-03-11 |
| Phase | Phase 1 |
What the finished NCT04882319 record still lists
NCT04882319 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (233% higher).
The record links to 0 conditions, and to 3 interventions - of which HP-5000 Topical Patch is the first listed.
NCT04882319 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04882319 about?
NCT04882319 is a clinical study titled "Irritation and Sensitization Study of HP-5000 Topical System". This study will assess skin irritation and sensitization for HP-5000 patch in healthy subjects.
What is the current status of trial NCT04882319?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2021-06-03. Estimated completion is 2022-03-11.
What interventions are being tested in trial NCT04882319?
The interventions under investigation include: HP-5000 Topical Patch (DRUG), HP-5000 Placebo Patch (DRUG), Saline Patch (DRUG).
Who is sponsoring clinical trial NCT04882319?
This trial is sponsored by Noven Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04882319's enrollment target sits among peer trials
200 259th of 2000 higher than 1,724 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI